Financials data is unavailable for this security.
Cash flow in CNYView more
In 2023, HighTide Therapeutics Inc increased its cash reserves by 122.75%, or 335.17m. Cash Flow from Financing totalled 361.10m or -- of revenues. In addition the company used 357.92m for operations while cash from investing totalled 316.66m.
Cash flow per share | -0.9246 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.28 |
---|---|
Tangible book value per share | 1.28 |
More ▼
Balance sheet in CNYView more
Current ratio | 10.88 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0421 |
---|---|
Total debt/total capital | 0.0404 |
More ▼